Cyclic AMP-induced inhibition of IgE-mediated hypersensitivity in human skin.
D000707:Anaphylaxis / Q000188:drug therapy; D000818:Animals; D000941:Antigens; D001681:Biological Assay; D000242:Cyclic AMP / Q000378:metabolism* / Q000494:pharmacology; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D004837:Epinephrine / Q000494:pharmacology; D006168:Guinea Pigs; D006636:Histamine Release / Q000187:drug effects*; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy / Q000378:metabolism*; D007073:Immunoglobulin E; D066298:In Vitro Techniques; D008954:Models, Biological; D011058:Pollen; D011433:Propranolol / Q000494:pharmacology; D012867:Skin / Q000378:metabolism*; D013806:Theophylline / Q000494:pharmacology
D000941:Antigens; D007073:Immunoglobulin E; D011433:Propranolol; D013806:Theophylline; D000242:Cyclic AMP; D004837:Epinephrine